TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
This Quarter Return
+4.28%
1 Year Return
+39.44%
3 Year Return
+251.65%
5 Year Return
+418.54%
10 Year Return
–
AUM
$739M
AUM Growth
+$739M
(+0.67%)
Cap. Flow
+$1.79M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
22.99%
Holding
106
New
18
Increased
48
Reduced
21
Closed
19
Top Buys
| 1 |
Clean Harbors
CLH
|
$13.7M |
| 2 |
Casella Waste Systems
CWST
|
$12.3M |
| 3 |
BlackLine
BL
|
$12M |
| 4 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
$11.9M |
| 5 |
Aspen Aerogels
ASPN
|
$9.49M |
Top Sells
| 1 |
Kirby Corp
KEX
|
$9.27M |
| 2 |
Element Solutions
ESI
|
$8.66M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
$7.78M |
| 4 |
PACW
PacWest Bancorp
PACW
|
$7.48M |
| 5 |
MSC Industrial Direct
MSM
|
$7.4M |
Sector Composition
| 1 | Technology | 31.59% |
| 2 | Healthcare | 21.24% |
| 3 | Industrials | 20.95% |
| 4 | Consumer Discretionary | 13.29% |
| 5 | Financials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Lattice Semiconductor
LSCC
$9.16B
| $7.47M | 1.01% |
115,585
+1,574
| +1% | +$102K |
|
52
Kaiser Aluminum
KALU
$1.22B
| $7.41M | 1% |
67,959
+926
| +1% | +$101K |
|
53
Bally's
BALY
$483M
| $7.4M | 1% |
147,577
+48,333
| +49% | +$2.42M |
|
54
Maximus
MMS
$4.99B
| $7.3M | 0.99% |
87,773
+1,200
| +1% | +$99.8K |
|
55
Bio-Techne
TECH
$8.3B
| $7.18M | 0.97% |
14,820
+202
| +1% | +$97.9K |
|
56
Charles River Laboratories
CRL
$7.99B
| $6.76M | 0.91% |
16,374
-3,427
| -17% | -$1.41M |
|
57
Kinsale Capital Group
KNSL
$10.5B
| $6.7M | 0.91% |
41,453
-44,547
| -52% | -$7.2M |
|
58
MKS Inc. Common Stock
MKSI
$6.73B
| $6.66M | 0.9% |
44,100
+602
| +1% | +$90.8K |
|
59
LeMaitre Vascular
LMAT
$2.14B
| $6.65M | 0.9% |
125,251
-71,094
| -36% | -$3.77M |
|
60
Trex
TREX
$6.41B
| $6.61M | 0.89% |
64,877
+881
| +1% | +$89.8K |
|
61
nCino
NCNO
$3.55B
| $6.27M | 0.85% |
88,272
+1,205
| +1% | +$85.6K |
|
62
Revolve Group
RVLV
$1.61B
| $6.21M | 0.84% |
100,458
-40,950
| -29% | -$2.53M |
|
63
Gentherm
THRM
$1.1B
| $5.93M | 0.8% |
+73,277
| New | +$5.93M |
|
|
LHCG
64
DELISTED
LHC Group LLC
LHCG
| $5.63M | 0.76% |
35,894
+489
| +1% | +$76.7K |
|
65
indie Semiconductor
INDI
$856M
| $5.6M | 0.76% |
+454,546
| New | +$5.6M |
|
66
Cohu
COHU
$899M
| $5.37M | 0.73% |
168,071
-115,866
| -41% | -$3.7M |
|
67
Establishment Labs
ESTA
$1.11B
| $5.15M | 0.7% |
71,958
+983
| +1% | +$70.4K |
|
68
Byrna Technologies
BYRN
$461M
| $5.01M | 0.68% |
+229,292
| New | +$5.01M |
|
|
DMTK
69
DELISTED
DermTech, Inc. Common Stock
DMTK
| $5M | 0.68% |
155,754
-4,617
| -3% | -$148K |
|
70
CyberArk
CYBR
$23B
| $4.69M | 0.64% |
+29,735
| New | +$4.69M |
|
71
Telos
TLS
$470M
| $4.53M | 0.61% |
159,549
+2,178
| +1% | +$61.9K |
|
72
Intellia Therapeutics
NTLA
$1.26B
| $4.25M | 0.57% |
+31,651
| New | +$4.25M |
|
|
BHVN
73
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.06M | 0.55% |
29,197
+389
| +1% | +$54K |
|
74
Arrowhead Research
ARWR
$3.84B
| $4M | 0.54% |
64,127
+858
| +1% | +$53.6K |
|
|
BPMC
75
DELISTED
Blueprint Medicines
BPMC
| $3.7M | 0.5% |
35,940
+2,666
| +8% | +$274K |
|